Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Elis M&A Activity 2019

Aug 26, 2019

1280_rns_2019-08-26_f74d4d6d-bb73-4ad5-9278-32a58974ff7c.html

M&A Activity

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

Elis closes the divestment of a division of Clinical Solutions in the UK

Saint-Cloud, 26 August 2019 – Elis, an international multi-service provider, offering textile, hygiene and facility services solutions across Europe and Latin America, has successfully completed the divestment of 100% of the Single Use (Rocialle) / Medical Consumables (Guardian) division of Clinical Solutions in the UK.

The new owners of Rocialle and Guardian, trading as Rocialle Healthcare Limited, are Multigate Medical Products UK Limited and New Beginnings Investment (Hong Kong) Co, Limited, respectively subsidiaries of Multigate Medical Products and Zhende Medical.

Contacts

**Nicolas Buron

**Investor Relations Director – Phone: +33 1 75 49 98 30 - [email protected]

**Audrey Bourgeois

**Investor Relations – Phone: +33 1 75 49 96 25 - [email protected]

Attachment